Index RUT
P/E -
EPS (ttm) -1.60
Insider Own 23.89%
Shs Outstand 49.08M
Perf Week -2.24%
Market Cap 818.81M
Forward P/E -
EPS next Y -0.16
Insider Trans -0.71%
Shs Float 39.06M
Perf Month 9.36%
Income -78.55M
PEG -
EPS next Q -0.08
Inst Own 72.12%
Short Float 3.51%
Perf Quarter -19.70%
Sales 198.82M
P/S 4.12
EPS this Y 41.72%
Inst Trans 1.16%
Short Ratio 2.85
Perf Half Y -33.69%
Book/sh 2.47
P/B 6.46
EPS next Y 52.40%
ROA -32.76%
Short Interest 1.37M
Perf Year 6.72%
Cash/sh 3.04
P/C 5.24
EPS next 5Y -
ROE -59.92%
52W Range 13.53 - 32.00
Perf YTD -29.15%
Dividend Est. -
P/FCF -
EPS past 5Y -23.52%
ROI -61.45%
52W High -50.14%
Beta 0.59
Dividend TTM -
Quick Ratio 1.84
Sales past 5Y 21.60%
Gross Margin 88.74%
52W Low 17.92%
ATR (14) 0.74
Dividend Ex-Date -
Current Ratio 1.84
EPS Y/Y TTM 3.70%
Oper. Margin -39.52%
RSI (14) 49.04
Volatility 3.74% 4.44%
Employees 796
Debt/Eq 0.03
Sales Y/Y TTM 21.00%
Profit Margin -39.51%
Recom 1.67
Target Price 23.14
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 11.45%
Payout -
Rel Volume 0.35
Prev Close 16.72
Sales Surprise 0.93%
EPS Surprise 30.56%
Sales Q/Q 19.59%
Earnings Sep 04 AMC
Avg Volume 481.19K
Price 15.95
SMA20 0.62%
SMA50 -2.03%
SMA200 -26.21%
Trades
Volume 127,936
Change -4.58%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-24 Resumed
Wedbush
Outperform
$26
Oct-07-24 Upgrade
Barclays
Equal Weight → Overweight
$19
Aug-16-24 Initiated
Piper Sandler
Overweight
$22
Jun-26-24 Initiated
Needham
Buy
$22
Jun-06-24 Downgrade
Goldman
Neutral → Sell
$18
May-22-24 Initiated
UBS
Neutral
$31
Feb-20-24 Downgrade
Barclays
Overweight → Equal Weight
$26 → $29
Jan-08-24 Initiated
Wells Fargo
Overweight
$26
Dec-14-23 Reiterated
Oppenheimer
Outperform
$23 → $25
Dec-07-23 Reiterated
Oppenheimer
Outperform
$20 → $23
Jan-27-23 Initiated
Guggenheim
Buy
$20
Dec-15-22 Initiated
Wedbush
Neutral
$16
Jun-15-22 Initiated
DA Davidson
Buy
$21
Aug-16-21 Initiated
William Blair
Outperform
Aug-16-21 Initiated
Stifel
Buy
$43
Aug-16-21 Initiated
Robert W. Baird
Outperform
$43
Aug-16-21 Initiated
RBC Capital Mkts
Outperform
$40
Aug-16-21 Initiated
Oppenheimer
Outperform
$40
Aug-16-21 Initiated
Morgan Stanley
Equal-Weight
$34
Aug-16-21 Initiated
Goldman
Neutral
$49
Show Previous Ratings
Oct-17-24 04:38AM
Oct-14-24 04:55AM
Oct-07-24 11:51AM
Sep-18-24 06:52AM
Sep-05-24 05:47PM
01:06PM
Loading…
01:06PM
(Thomson Reuters StreetEvents)
12:43PM
Sep-04-24 06:00PM
05:15PM
04:10PM
04:05PM
Sep-03-24 09:03AM
09:00AM
03:01AM
Aug-30-24 04:30PM
09:00AM
Loading…
09:00AM
Aug-23-24 07:59AM
Aug-14-24 09:00AM
Jul-26-24 04:04AM
Jul-15-24 04:08AM
Jun-25-24 02:11AM
Jun-12-24 06:17AM
Jun-10-24 06:12AM
Jun-05-24 08:53PM
06:00PM
05:15PM
04:14PM
04:05PM
Jun-04-24 03:02AM
Jun-01-24 02:43AM
04:30PM
Loading…
May-31-24 04:30PM
May-18-24 02:37AM
May-15-24 09:00AM
May-06-24 09:00AM
Apr-18-24 01:41AM
Apr-16-24 11:55AM
Apr-15-24 12:21PM
Apr-09-24 05:03AM
Apr-08-24 02:46PM
Apr-03-24 07:01PM
10:42AM
Mar-31-24 03:34PM
Mar-27-24 04:36PM
Mar-26-24 07:01PM
08:30AM
Mar-07-24 01:25PM
11:05AM
09:00AM
Mar-06-24 07:04PM
04:27PM
12:59PM
12:21PM
(Investor's Business Daily)
11:10AM
(Investor's Business Daily)
11:06AM
07:21AM
(Thomson Reuters StreetEvents)
Mar-05-24 10:52PM
06:00PM
04:11PM
04:05PM
Mar-04-24 02:00AM
Mar-01-24 04:30PM
Feb-29-24 09:15AM
09:00AM
Feb-21-24 09:00AM
Feb-15-24 09:00AM
Feb-07-24 02:40AM
Jan-25-24 11:50PM
03:46AM
Jan-24-24 05:24AM
Jan-22-24 04:02AM
Jan-12-24 02:48AM
Jan-08-24 08:30AM
Jan-05-24 11:02AM
Jan-04-24 09:00AM
Dec-21-23 05:01AM
Dec-08-23 09:26AM
Dec-06-23 05:30PM
05:27PM
05:15PM
04:20PM
04:05PM
Dec-05-23 02:01AM
Dec-01-23 04:15PM
Nov-27-23 09:00AM
Nov-16-23 09:00AM
09:00AM
Nov-07-23 10:32AM
Oct-20-23 10:51AM
Oct-18-23 09:34AM
Oct-16-23 10:00AM
Oct-05-23 10:13AM
Sep-26-23 10:07AM
Sep-25-23 09:00AM
Sep-07-23 04:02PM
11:32AM
(Thomson Reuters StreetEvents)
09:30AM
08:46AM
Sep-06-23 05:15PM
04:05PM
Sep-01-23 04:00PM
Couchbase, Inc. engages in the development of document database management solutions. It offers its Couchbase platform to developers to build enterprise web, mobile, and Internet of things applications that support massive data volumes in real time. The company was founded by Phillips James, Dustin Sallings, Damien Katz, Jan Lehnardt, Phillips James, and J. Chris Anderson in 2008, and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Carpenter Carol W. Director Oct 01 '24 Sale 16.00 900 14,400 24,427 Oct 03 06:09 PM Henry Gregory N SVP & Chief Financial Officer Sep 27 '24 Sale 15.01 2,908 43,661 365,215 Sep 30 04:54 PM Henry Gregory N SVP & Chief Financial Officer Sep 26 '24 Sale 15.00 1,100 16,501 368,123 Sep 30 04:54 PM Owen Huw SVP & Chief Revenue Officer Sep 27 '24 Sale 15.07 6,736 101,544 373,647 Sep 30 04:53 PM Owen Huw SVP & Chief Revenue Officer Sep 26 '24 Sale 15.00 1,100 16,501 380,383 Sep 30 04:53 PM THE HENRY FAMILY TRUST Officer Sep 26 '24 Proposed Sale 14.47 4,008 57,996 Sep 26 04:25 PM HUW OWEN Officer Sep 26 '24 Proposed Sale 14.47 7,836 113,387 Sep 26 04:24 PM ANDERSON EDWARD T Director Sep 19 '24 Buy 14.16 21,080 298,484 85,902 Sep 23 05:20 PM Carpenter Carol W. Director Sep 03 '24 Sale 19.28 900 17,352 25,327 Sep 05 04:33 PM Carpenter Carol W. Director Aug 01 '24 Sale 19.06 900 17,154 26,227 Aug 05 05:10 PM Epstein Jeff Director Jul 25 '24 Option Exercise 5.15 12,723 65,523 40,750 Jul 29 05:15 PM Epstein Jeff Director Jul 26 '24 Option Exercise 5.15 7,277 37,477 35,304 Jul 29 05:15 PM Epstein Jeff Director Jul 25 '24 Sale 20.01 12,723 254,625 28,027 Jul 29 05:15 PM Epstein Jeff Director Jul 26 '24 Sale 20.10 7,277 146,265 28,027 Jul 29 05:15 PM Chow Margaret SVP & Chief Legal Officer Jul 25 '24 Sale 20.00 2,290 45,804 192,458 Jul 29 05:13 PM Owen Huw SVP & Chief Revenue Officer Jul 25 '24 Sale 20.01 3,895 77,943 401,228 Jul 29 05:12 PM Cain Matthew M Chair, President, and CEO Jul 25 '24 Sale 20.01 8,953 179,147 776,437 Jul 29 05:11 PM Henry Gregory N SVP & Chief Financial Officer Jul 24 '24 Option Exercise 4.67 21,390 99,998 22,390 Jul 26 05:17 PM Carpenter Carol W. Director Jul 08 '24 Sale 18.19 900 16,371 27,127 Jul 10 05:52 PM Owen Huw SVP & Chief Revenue Officer Jun 24 '24 Sale 16.84 7,792 131,206 405,123 Jun 24 05:55 PM Owen Huw SVP & Chief Revenue Officer Jun 20 '24 Sale 16.53 2,993 49,484 412,915 Jun 24 05:55 PM Henry Gregory N SVP & Chief Financial Officer Jun 20 '24 Sale 16.52 3,982 65,795 393,060 Jun 24 05:54 PM Cain Matthew M Chair, President, and CEO Jun 03 '24 Sale 22.05 18,101 399,197 855,304 Jun 05 05:07 PM Christensen Lynn M Director May 29 '24 Sale 25.76 9,874 254,396 1,229 May 31 06:07 PM Chow Margaret SVP & Chief Legal Officer May 17 '24 Option Exercise 7.75 3,934 30,488 214,363 May 21 05:45 PM Chow Margaret SVP & Chief Legal Officer May 20 '24 Option Exercise 7.75 1,066 8,262 211,495 May 21 05:45 PM Chow Margaret SVP & Chief Legal Officer May 17 '24 Sale 27.53 3,934 108,307 210,429 May 21 05:45 PM Chow Margaret SVP & Chief Legal Officer May 20 '24 Sale 27.50 1,066 29,315 210,429 May 21 05:45 PM Cain Matthew M Chair, President, and CEO May 15 '24 Sale 26.58 10,053 267,174 873,405 May 17 06:55 PM Cain Matthew M Chair, President, and CEO Apr 15 '24 Sale 24.15 10,053 242,815 883,458 Apr 17 05:35 PM Chow Margaret SVP & Chief Legal Officer Apr 01 '24 Option Exercise 7.75 3,000 23,250 213,429 Apr 03 04:06 PM Chow Margaret SVP & Chief Legal Officer Apr 01 '24 Sale 26.19 5,525 144,677 210,429 Apr 03 04:06 PM Owen Huw SVP & Chief Revenue Officer Mar 22 '24 Sale 26.79 11,581 310,201 441,454 Mar 26 05:01 PM Henry Gregory N SVP & Chief Financial Officer Mar 21 '24 Sale 27.84 18,747 521,858 330,652 Mar 25 05:51 PM Carey William Robert Chief Accounting Officer Mar 21 '24 Sale 27.90 4,431 123,647 48,097 Mar 25 05:50 PM Carey William Robert Chief Accounting Officer Mar 18 '24 Sale 27.20 416 11,315 52,528 Mar 20 06:05 PM Chow Margaret SVP & Chief Legal Officer Mar 06 '24 Option Exercise 7.75 10,000 77,500 227,700 Mar 08 05:58 PM Chow Margaret SVP & Chief Legal Officer Mar 06 '24 Sale 30.53 10,000 305,279 217,700 Mar 08 05:58 PM Owen Huw SVP & Chief Revenue Officer Mar 06 '24 Option Exercise 7.52 13,605 102,357 481,572 Mar 08 05:56 PM Owen Huw SVP & Chief Revenue Officer Mar 06 '24 Sale 30.33 13,605 412,671 467,967 Mar 08 05:56 PM Chow Margaret SVP & Chief Legal Officer Feb 02 '24 Option Exercise 7.75 4,620 35,805 166,723 Feb 06 05:35 PM Chow Margaret SVP & Chief Legal Officer Feb 05 '24 Option Exercise 7.75 380 2,945 162,483 Feb 06 05:35 PM Chow Margaret SVP & Chief Legal Officer Feb 02 '24 Sale 27.50 4,620 127,073 162,103 Feb 06 05:35 PM Chow Margaret SVP & Chief Legal Officer Feb 05 '24 Sale 27.50 380 10,450 162,103 Feb 06 05:35 PM Cain Matthew M Chair, President, and CEO Feb 01 '24 Sale 25.72 18,101 465,585 633,118 Feb 05 05:51 PM Owen Huw SVP & Chief Revenue Officer Jan 25 '24 Option Exercise 9.95 1,376 13,691 385,947 Jan 29 05:43 PM Owen Huw SVP & Chief Revenue Officer Jan 25 '24 Sale 25.00 1,376 34,405 384,571 Jan 29 05:43 PM Owen Huw SVP & Chief Revenue Officer Jan 24 '24 Option Exercise 7.99 18,124 144,734 402,695 Jan 25 07:33 PM Owen Huw SVP & Chief Revenue Officer Jan 23 '24 Option Exercise 7.55 3,500 26,425 388,071 Jan 25 07:33 PM Owen Huw SVP & Chief Revenue Officer Jan 24 '24 Sale 25.02 18,124 453,433 384,571 Jan 25 07:33 PM Owen Huw SVP & Chief Revenue Officer Jan 23 '24 Sale 25.00 3,500 87,504 384,571 Jan 25 07:33 PM Chow Margaret SVP & Chief Legal Officer Jan 23 '24 Option Exercise 7.75 3,000 23,250 165,103 Jan 25 07:32 PM Chow Margaret SVP & Chief Legal Officer Jan 23 '24 Sale 25.00 3,000 75,004 162,103 Jan 25 07:32 PM Christensen Lynn M Director Jan 04 '24 Sale 20.52 14,532 298,163 10,800 Jan 08 06:25 PM Henry Gregory N SVP & Chief Financial Officer Jan 03 '24 Sale 20.73 36,551 757,527 362,433 Jan 05 05:39 PM Owen Huw SVP & Chief Revenue Officer Jan 02 '24 Sale 21.38 40,604 868,292 394,704 Jan 04 05:18 PM Owen Huw SVP & Chief Revenue Officer Jan 03 '24 Sale 20.71 10,133 209,836 384,571 Jan 04 05:18 PM Chow Margaret SVP & Chief Legal Officer Jan 02 '24 Sale 21.35 2,360 50,391 162,103 Jan 04 05:17 PM Owen Huw SVP & Chief Revenue Officer Dec 21 '23 Sale 22.49 3,211 72,203 435,308 Dec 22 01:09 PM Chow Margaret SVP & Chief Legal Officer Dec 18 '23 Sale 23.59 4,989 117,691 164,463 Dec 20 07:05 PM Cain Matthew M Chair, President, and CEO Dec 18 '23 Option Exercise 5.48 60,000 328,800 711,219 Dec 20 07:04 PM Cain Matthew M Chair, President, and CEO Dec 18 '23 Sale 23.69 78,927 1,870,066 651,219 Dec 20 07:04 PM Carey William Robert Chief Accounting Officer Dec 18 '23 Sale 23.59 1,287 30,360 53,230 Dec 20 07:03 PM Carey William Robert Chief Accounting Officer Dec 20 '23 Sale 23.15 452 10,464 52,778 Dec 20 07:03 PM Owen Huw SVP & Chief Revenue Officer Dec 18 '23 Sale 23.59 14,459 341,088 438,519 Dec 20 07:03 PM Henry Gregory N SVP & Chief Financial Officer Dec 18 '23 Sale 23.59 15,957 376,426 403,158 Dec 20 07:01 PM Henry Gregory N SVP & Chief Financial Officer Dec 20 '23 Sale 23.11 4,174 96,480 398,984 Dec 20 07:01 PM Carey William Robert Chief Accounting Officer Dec 01 '23 Sale 20.00 1,000 20,000 54,517 Dec 05 05:23 PM Chow Margaret SVP & Chief Legal Officer Nov 14 '23 Sale 18.00 1,153 20,754 169,452 Nov 16 06:29 PM
Index RUT
P/E -
EPS (ttm) -1.63
Insider Own 13.84%
Shs Outstand 57.21M
Perf Week 17.82%
Market Cap 18.53M
Forward P/E -
EPS next Y -0.74
Insider Trans 0.00%
Shs Float 56.40M
Perf Month 3.36%
Income -101.39M
PEG -
EPS next Q -0.21
Inst Own 45.91%
Short Float 5.06%
Perf Quarter -8.41%
Sales 1.82M
P/S 10.18
EPS this Y -5.71%
Inst Trans -45.45%
Short Ratio 3.28
Perf Half Y -94.59%
Book/sh 0.47
P/B 0.60
EPS next Y 44.14%
ROA -92.07%
Short Interest 2.85M
Perf Year -91.55%
Cash/sh 1.03
P/C 0.27
EPS next 5Y -1.60%
ROE -156.52%
52W Range 0.21 - 6.79
Perf YTD -94.60%
Dividend Est. -
P/FCF -
EPS past 5Y -21.63%
ROI -159.78%
52W High -95.83%
Beta -0.02
Dividend TTM -
Quick Ratio 3.60
Sales past 5Y 58.51%
Gross Margin -
52W Low 34.44%
ATR (14) 0.02
Dividend Ex-Date -
Current Ratio 3.60
EPS Y/Y TTM 1.30%
Oper. Margin -4100.71%
RSI (14) 62.18
Volatility 8.46% 7.74%
Employees 88
Debt/Eq 1.19
Sales Y/Y TTM 47.01%
Profit Margin -5570.88%
Recom 2.60
Target Price 0.50
Option/Short Yes / Yes
LT Debt/Eq 1.05
EPS Q/Q -105.62%
Payout -
Rel Volume 5.22
Prev Close 0.25
Sales Surprise 12.41%
EPS Surprise -121.36%
Sales Q/Q 30.57%
Earnings Aug 14 AMC
Avg Volume 871.19K
Price 0.28
SMA20 17.93%
SMA50 4.04%
SMA200 -87.80%
Trades
Volume 3,425,568
Change 12.30%
Date
Action
Analyst
Rating Change
Price Target Change
May-07-24 Downgrade
Jefferies
Buy → Hold
$10 → $0.50
May-07-24 Downgrade
H.C. Wainwright
Buy → Neutral
$12 → $2
May-07-24 Downgrade
BofA Securities
Buy → Underperform
May-06-24 Downgrade
William Blair
Outperform → Mkt Perform
Oct-06-23 Resumed
BTIG Research
Buy
$15
Aug-31-23 Initiated
H.C. Wainwright
Buy
$12
May-24-22 Initiated
Cantor Fitzgerald
Overweight
$15
May-26-20 Initiated
William Blair
Outperform
May-26-20 Initiated
Jefferies
Buy
$24
May-26-20 Initiated
BTIG Research
Buy
$28
May-26-20 Initiated
BofA/Merrill
Buy
$21
Show Previous Ratings
Oct-15-24 07:00AM
Sep-27-24 07:00AM
Aug-14-24 09:54PM
05:30PM
04:01PM
11:35AM
Loading…
Jul-15-24 11:35AM
May-21-24 10:31AM
09:14AM
May-07-24 09:54AM
07:39AM
07:38AM
May-06-24 12:08PM
11:32AM
11:07AM
10:51AM
08:52AM
Loading…
08:52AM
07:59AM
Apr-30-24 09:56PM
05:30PM
04:04PM
Apr-26-24 04:51PM
Mar-28-24 07:08AM
Mar-25-24 08:50AM
Mar-23-24 05:31AM
Mar-22-24 09:55AM
Mar-21-24 10:54PM
04:01PM
Mar-08-24 08:50AM
Mar-01-24 04:01PM
Feb-26-24 03:58AM
08:50AM
Loading…
Feb-21-24 08:50AM
Jan-17-24 08:50AM
Nov-07-23 04:01PM
07:00AM
Oct-16-23 07:00AM
Sep-13-23 01:22PM
Sep-12-23 07:00AM
Sep-06-23 08:00AM
Aug-29-23 07:00AM
Aug-08-23 05:50PM
04:01PM
Jul-13-23 07:30AM
Jun-02-23 04:01PM
07:30AM
Jun-01-23 07:29AM
May-26-23 07:57AM
May-14-23 08:19AM
May-12-23 08:15AM
07:00AM
May-09-23 04:01PM
Apr-29-23 08:19AM
Apr-25-23 07:59AM
Mar-29-23 04:06PM
Mar-20-23 01:11PM
Mar-01-23 05:21AM
Feb-28-23 05:17AM
Feb-27-23 07:59AM
Feb-07-23 01:23PM
Feb-06-23 07:56AM
Jan-17-23 06:42PM
Dec-20-22 08:52AM
Nov-09-22 08:00AM
Nov-08-22 05:45PM
04:01PM
Sep-21-22 06:11AM
Sep-13-22 04:01PM
07:00AM
Sep-10-22 08:00AM
Sep-08-22 07:00AM
Sep-06-22 07:00AM
Aug-31-22 02:08PM
Aug-29-22 07:00AM
Aug-11-22 08:05AM
Aug-09-22 08:25AM
07:00AM
Jul-27-22 09:40AM
Jul-13-22 09:21AM
Jul-05-22 07:00AM
07:00AM
Jun-17-22 04:01PM
May-26-22 07:00AM
May-25-22 01:07PM
May-10-22 08:35AM
07:00AM
May-05-22 07:00AM
Apr-29-22 09:07AM
Apr-27-22 06:31AM
Apr-25-22 07:00AM
Apr-21-22 07:00AM
Apr-13-22 07:00AM
Apr-08-22 07:34AM
Mar-09-22 07:00AM
Mar-07-22 07:00AM
Mar-02-22 04:28AM
Feb-28-22 07:00AM
Feb-17-22 07:00AM
Jan-24-22 12:37PM
07:00AM
Nov-11-21 07:00AM
Nov-09-21 04:05PM
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer in November 2005 and is headquartered in Watertown, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Waksal Harlan Executive Chair Nov 10 '23 Buy 2.96 25,000 74,095 261,966 Nov 13 05:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite